Holen Sie sich die Stockscreener-App
18.05
0.22%
0.04
Schlusskurs vom Vortag:
$18.01
Offen:
$17.85
24-Stunden-Volumen:
1.50M
Relative Volume:
0.96
Marktkapitalisierung:
$1.48B
Einnahmen:
$1.29B
Nettoeinkommen (Verlust:
$58.52M
KGV:
27.65
EPS:
0.6528
Netto-Cashflow:
$191.78M
1W Leistung:
+0.00%
1M Leistung:
-13.14%
6M Leistung:
-16.75%
1J Leistung:
-18.14%
1-Tages-Spanne:
$17.59
$18.15
1-Wochen-Bereich:
$17.59
$18.60
52-Wochen-Spanne:
$16.75
$28.75
Progyny Inc Stock (PGNY) Company Profile
Firmenname
Progyny Inc
Sektor
Branche
Telefon
212-888-3124
Adresse
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
18.05 | 1.48B | 1.29B | 58.52M | 191.78M | 0.6528 |
UNH
Unitedhealth Group Inc
|
272.28 | 247.14B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
72.80 | 92.62B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
265.87 | 70.10B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
290.33 | 64.08B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
172.23 | 20.68B | 129.66B | 1.20B | 375.00M | 9.8083 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-08 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-12-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-13 | Herabstufung | Truist | Buy → Hold |
| 2024-09-19 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-08-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-22 | Eingeleitet | BTIG Research | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-05 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | Eingeleitet | Truist | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Berenberg | Buy |
| 2021-08-12 | Eingeleitet | Barclays | Overweight |
| 2021-06-02 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-02 | Eingeleitet | Guggenheim | Buy |
| 2019-11-19 | Eingeleitet | Citigroup | Buy |
| 2019-11-19 | Eingeleitet | Goldman | Buy |
| 2019-11-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-11-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-11-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Progyny Inc Aktie (PGNY) Neueste Nachrichten
Trading the Move, Not the Narrative: (PGNY) Edition - Stock Traders Daily
Retail Trends: Is Progyny Inc forming a bullish divergencePortfolio Performance Summary & Long Hold Capital Preservation Tips - baoquankhu1.vn
Progyny, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Progyny CEO Details Utilization Trends, Forecasting and Progyny Select Fully Insured Rollout at Conference - MarketBeat
Why is Progyny Inc stock going downWeekly Trade Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Barclays Cuts Progyny (NASDAQ:PGNY) Price Target to $23.00 - MarketBeat
Barclays Lowers Price Target for Progyny (PGNY), Maintains Overw - GuruFocus
Progyny (PGNY) Chief Product Officer has RSU shares withheld for taxes - Stock Titan
Barclays cuts Progyny stock price target on membership concerns By Investing.com - Investing.com Canada
Barclays cuts Progyny stock price target on membership concerns - Investing.com
J.P. Morgan Reaffirms Their Hold Rating on Progyny (PGNY) - The Globe and Mail
Recap Report: What analysts say about Progyny Inc stock2026 Big Picture & Real-Time Buy Signal Notifications - baoquankhu1.vn
Assessing Progyny (PGNY) Valuation After Prolonged Share Price Weakness - simplywall.st
Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny at KeyBanc Forum: Strategic Growth and Challenges By Investing.com - Investing.com India
Progyny at KeyBanc Forum: Strategic Growth and Challenges - Investing.com
Targets Report: Is Progyny Inc attractive for institutional investors2026 EndofMonth & Daily Stock Trend Reports - baoquankhu1.vn
Progyny, Inc. $PGNY Shares Purchased by Algert Global LLC - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Sees Significant Growth in Short Interest - MarketBeat
Progyny Announces Settlement, Governance Reforms on Director Pay - The Globe and Mail
Is Progyny (PGNY) Pricing Reflect Its Steep Multi‑Year Share Price Declines Today - simplywall.st
Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook - AOL.com
Assessing Progyny (PGNY) Valuation After Recent Share Price Weakness - Yahoo Finance
Progyny Inc. Announces Notice of Pendency of Settlement of Derivative Action – Corporate Information and SEC Filing Details - Minichart
(PGNY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Progyny issues notice of settlement for derivative action regarding director pay - Investing.com
Progyny Issues Notice Of Pendency Of Settlement Of Derivative Action - TradingView
Progyny agrees to settle derivative suit, adopts new director pay limits and governance reforms - TradingView
Proposed Progyny (NASDAQ: PGNY) director pay settlement adds governance reforms - Stock Titan
Progyny (PGNY) Receives a Hold from Canaccord Genuity - The Globe and Mail
Progyny at Barclays Healthcare Conference: Strategic Growth Amid Challenges By Investing.com - Investing.com Canada
Canaccord Genuity Group Lowers Progyny (NASDAQ:PGNY) Price Target to $19.00 - MarketBeat
Canaccord lowers Progyny stock price target on covered lives concerns By Investing.com - Investing.com Canada
Progyny’s Dual Use of Buybacks and ESOP Shares Raises a Key Capital Allocation Question (PGNY) - simplywall.st
Barclays PLC Purchases 696,447 Shares of Progyny, Inc. $PGNY - MarketBeat
Progyny at Leerink Conference: Strategic Expansion in Healthcare By Investing.com - Investing.com South Africa
Progyny at Leerink Conference: Strategic Expansion in Healthcare - Investing.com
Quantbot Technologies Reduces Stake in Progyny - National Today
Quantbot Technologies LP Reduces Stock Position in Progyny, Inc. $PGNY - MarketBeat
Progyny, Inc. $PGNY Shares Bought by Dynamic Technology Lab Private Ltd - MarketBeat
Progyny, Inc. Hits New 52-Week Low at $16.75 Amid Declining Performance - Markets Mojo
PGNY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
US Stocks Recap: Is Progyny Inc a good ESG investmentMarket Trend Summary & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Jefferies Maintains Buy on PGNY (Progyny, Inc.) March 2026 - Meyka
Progyny's Valuation Upgrade Reflects Improved Financial Metrics Amid Market Dynamics - Markets Mojo
Will Progyny Inc. stock deliver strong dividend growthPortfolio Value Report & Reliable Breakout Stock Forecasts - Naître et grandir
Progyny (PGNY) EVP GC sells shares under 10b5-1 plan, pays tax - Stock Titan
Progyny (PGNY) CFO reports 339-share tax-withholding disposition on Form 4 - Stock Titan
Jefferies cuts Progyny stock price target on guidance miss By Investing.com - Investing.com Australia
Jefferies cuts Progyny stock price target on guidance miss - Investing.com India
Progyny, Inc. Leadership to Participate in Key Investor Conferences in March 2026 - Quiver Quantitative
Finanzdaten der Progyny Inc-Aktie (PGNY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):